Johnson & Johnson Price to Sales Ratio 2010-2023 | JNJ

Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of March 01, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-03-01 162.12 4.45
2023-12-31 155.56 $36.40 4.27
2023-09-30 153.36 $37.92 4.04
2023-06-30 161.82 $37.06 4.37
2023-03-31 150.39 $36.34 4.14
2022-12-31 170.20 $35.63 4.78
2022-09-30 156.39 $34.58 4.52
2022-06-30 168.80 $35.79 4.72
2022-03-31 167.48 $35.14 4.77
2021-12-31 160.62 $34.77 4.62
2021-09-30 150.63 $33.39 4.51
2021-03-31 151.44 $31.54 4.80
2020-12-31 144.12 $30.94 4.66
2020-09-30 135.38 $30.25 4.48
2020-06-30 127.04 $30.12 4.22
2020-03-31 117.63 $30.88 3.81
2019-12-31 130.01 $30.55 4.26
2019-09-30 114.52 $30.30 3.78
2019-06-30 123.28 $31.26 3.94
2019-03-31 122.89 $31.08 3.95
2018-12-31 112.71 $31.31 3.60
2021-06-30 152.74 $31.16 4.90
2018-09-30 119.91 $29.79 4.02
2018-06-30 104.60 $29.51 3.54
2018-03-31 109.66 $28.73 3.82
2017-12-31 118.81 $27.86 4.27
2017-09-30 109.88 $26.99 4.07
2017-06-30 111.10 $26.21 4.24
2017-03-31 103.92 $25.95 4.00
2016-12-31 95.50 $25.74 3.71
2016-09-30 97.25 $25.58 3.80
2016-06-30 99.20 $25.27 3.92
2016-03-31 87.86 $24.98 3.52
2015-12-31 82.81 $24.90 3.33
2015-09-30 74.71 $24.94 3.00
2015-06-30 77.39 $25.29 3.06
2015-03-31 79.31 $25.75 3.08
2014-12-31 81.86 $25.91 3.16
2014-09-30 82.91 $25.91 3.20
2014-06-30 80.83 $25.56 3.16
2014-03-31 75.37 $24.96 3.02
2013-12-31 69.77 $24.78 2.82
2013-09-30 65.58 $24.65 2.66
2013-06-30 64.47 $24.60 2.62
2013-03-31 60.76 $24.30 2.50
2012-12-31 51.83 $24.00 2.16
2012-09-30 50.51 $23.61 2.14
2012-06-30 49.07 $23.32 2.10
2012-03-31 47.45 $23.40 2.03
2011-12-31 46.77 $23.42 2.00
2011-09-30 45.00 $23.17 1.94
2011-06-30 46.59 $22.79 2.04
2011-03-31 41.14 $22.30 1.84
2010-12-31 42.56 $22.06 1.93
2010-09-30 42.27 $22.38 1.89
2010-06-30 39.91 $22.40 1.78
2010-03-31 43.66 $22.40 1.95
2009-12-31 42.81 $22.20 1.93
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $390.509B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $743.142B 123.75
Novo Nordisk (NVO) Denmark $557.486B 45.93
Merck (MRK) United States $321.545B 84.64
AbbVie (ABBV) United States $316.040B 16.10
Novartis AG (NVS) Switzerland $216.326B 14.99
AstraZeneca (AZN) United Kingdom $200.284B 17.75
Pfizer (PFE) United States $150.148B 14.53
Sanofi (SNY) $119.624B 10.77
Innoviva (INVA) United States $0.977B 6.80